Gfs Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

Gfs Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$9.9 - $11.56 $358,380 - $418,472	-36,200 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$10.34 - $12.81 $361,900 - $448,350	-35,000 Reduced 49.16%	36,200 $418,000
Q1 2020 May 05, 2020	BUY	$6.69 - $13.45 $4,683 - $9,415	700 Added 0.99%	71,200 $639,000
Q4 2019 Jan 17, 2020	BUY	$6.53 - $10.72 $6,530 - $10,720	1,000 Added 1.44%	70,500 $691,000
Q2 2019 Aug 01, 2019	BUY	$8.12 - $15.72 $414,119 - $801,720	51,000 Added 275.68%	69,500 $641,000
Q1 2019 May 13, 2019	SELL	$15.58 - $20.01 $38,950 - $50,025	-2,500 Reduced 11.9%	18,500 $290,000
Q4 2018 Feb 12, 2019	SELL	$14.59 - $23.84 $9,483 - $15,496	-650 Reduced 3.0%	21,000 $324,000
Q2 2018 Aug 08, 2018	SELL	$16.77 - $24.71 $33,540 - $49,420	-2,000 Reduced 8.46%	21,650 $527,000
Q1 2018 May 09, 2018	SELL	$16.68 - $22.07 $83,400 - $110,350	-5,000 Reduced 17.45%	23,650 $404,000
Q4 2017 Feb 09, 2018	SELL	$11.23 - $19.1 $119,599 - $203,415	-10,650 Reduced 27.1%	28,650 $543,000
Q3 2017 Nov 07, 2017	BUY	$15.41 - $32.17 $70,115 - $146,373	4,550 Added 13.09%	39,300 $692,000
Q2 2017 Aug 07, 2017	BUY	N/A	34,750	34,750 $1.15 Million

629

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfs Advisors, LLC with notifications on news.